{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:43:39Z","timestamp":1773103419243,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,7]]},"DOI":"10.7759\/cureus.64013","type":"journal-article","created":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T13:27:22Z","timestamp":1720358842000},"source":"Crossref","is-referenced-by-count":2,"title":["Lichenoid Drug Eruption Secondary to Adalimumab: A Case Report"],"prefix":"10.7759","author":[{"given":"Asma","family":"Alkheraiji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hend","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Husna","family":"Irfan Thalib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2015.1134581","article-title":"Adalimumab for ocular inflammation","volume":"25","author":"Durrani K","year":"2017","unstructured":"Durrani K, Kempen JH, Ying GS, et al.. Adalimumab for ocular inflammation. Ocul Immunol Inflamm. 2017, 25:405-12. 10.3109\/09273948.2015.1134581","journal-title":"Ocul Immunol Inflamm"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2007.02413.x","article-title":"Lichenoid reaction induced by adalimumab","volume":"22","author":"De Simone C","year":"2008","unstructured":"De Simone C, Caldarola G, D'Agostino M, Rotoli M, Capizzi R, Amerio P. Lichenoid reaction induced by adalimumab. J Eur Acad Dermatol Venereol. 2008, 22:626-7. 10.1111\/j.1468-3083.2007.02413.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.02.010","article-title":"Lichen planus and lichenoid dermatoses: clinical overview and molecular basis","volume":"79","author":"Tziotzios C","year":"2018","unstructured":"Tziotzios C, Lee JY, Brier T, et al.. Lichen planus and lichenoid dermatoses: clinical overview and molecular basis. J Am Acad Dermatol. 2018, 79:789-804. 10.1016\/j.jaad.2018.02.010","journal-title":"J Am Acad Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2007.08.013","article-title":"TNFalpha blockade in human diseases: mechanisms and future directions","volume":"126","author":"Wong M","year":"2008","unstructured":"Wong M, Ziring D, Korin Y, et al.. TNFalpha blockade in human diseases: mechanisms and future directions. Clin Immunol. 2008, 126:121-36. 10.1016\/j.clim.2007.08.013","journal-title":"Clin Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-011-8262-2","article-title":"Skin manifestations induced by TNF-alpha inhibitors in juvenile idiopathic arthritis","volume":"42","author":"Pontikaki I","year":"2012","unstructured":"Pontikaki I, Shahi E, Frasin LA, Gianotti R, Gelmetti C, Gerloni V, Meroni PL. Skin manifestations induced by TNF-alpha inhibitors in juvenile idiopathic arthritis. Clin Rev Allergy Immunol. 2012, 42:131-4. 10.1007\/s12016-011-8262-2","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/ar1724","article-title":"Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study","volume":"7","author":"Flendrie M","year":"2005","unstructured":"Flendrie M, Vissers WH, Creemers MC, de Jong EM, van de Kerkhof PC, van Riel PL. Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study. Arthritis Res Ther. 2005, 7:R666-76. 10.1186\/ar1724","journal-title":"Arthritis Res Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.12816\/0008295","article-title":"Adalimumab-induced lichenoid drug eruption","volume":"62","author":"El Habr C","year":"2014","unstructured":"El Habr C, Meguerian Z, Sammour R. Adalimumab-induced lichenoid drug eruption. J Med Liban. 2014, 62:238-40. 10.12816\/0008295","journal-title":"J Med Liban"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.09.032","article-title":"Lichen planus-like eruptions: an emerging side effect of tumor necrosis factor-alpha antagonists","volume":"61","author":"Asarch A","year":"2009","unstructured":"Asarch A, Gottlieb AB, Lee J, et al.. Lichen planus-like eruptions: an emerging side effect of tumor necrosis factor-alpha antagonists. J Am Acad Dermatol. 2009, 61:104-11. 10.1016\/j.jaad.2008.09.032","journal-title":"J Am Acad Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/03009740902922612","article-title":"Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors","volume":"38","author":"Exarchou SA","year":"2009","unstructured":"Exarchou SA, Voulgari PV, Markatseli TE, Zioga A, Drosos AA. Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors. Scand J Rheumatol. 2009, 38:328-31. 10.1080\/03009740902922612","journal-title":"Scand J Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2022.07.007","article-title":"Annular lichenoid eruption following treatment with casirivimab\/imdevimab for COVID-19","volume":"27","author":"Markovitz NH","year":"2022","unstructured":"Markovitz NH, Pedersen E, Sachs DL, Bresler SC. Annular lichenoid eruption following treatment with casirivimab\/imdevimab for COVID-19. JAAD Case Rep. 2022, 27:156-8. 10.1016\/j.jdcr.2022.07.007","journal-title":"JAAD Case Rep"},{"key":"ref11","article-title":"The first case of adalimumab-induced hypertrophic lichen planus","volume":"12","author":"Saad S","year":"2021","unstructured":"Saad S, Korbi M, Bejia I, Belhadjali H, Zili J. The first case of adalimumab-induced hypertrophic lichen planus. Our Dermatol Online. 2021, 12:341-2.","journal-title":"Our Dermatol Online"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.5070\/D32612051366","article-title":"Lichenoid drug eruption after treatment with ixekizumab for plaque psoriasis","volume":"26","author":"Ghiam N","year":"2020","unstructured":"Ghiam N, Ojong O, Vasile G, Romanelli P, Kerdel F. Lichenoid drug eruption after treatment with ixekizumab for plaque psoriasis. Dermatol Online J. 2020, 26:","journal-title":"Dermatol Online J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2012.07.017","article-title":"Lichen planus under anti TNF therapy for ankylosing spondylitis","volume":"80","author":"Wendling D","year":"2013","unstructured":"Wendling D, Biver-Dalle C, Vidon C, Prati C, Aubin F. Lichen planus under anti TNF therapy for ankylosing spondylitis. Joint Bone Spine. 2013, 80:227-8. 10.1016\/j.jbspin.2012.07.017","journal-title":"Joint Bone Spine"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.138.9.1258","article-title":"Cutaneous drug eruption to infliximab: report of 4 cases with an interface dermatitis pattern","volume":"138","author":"Vergara G","year":"2002","unstructured":"Vergara G, Silvestre JF, Betlloch I, Vela P, Albares MP, Pascual JC. Cutaneous drug eruption to infliximab: report of 4 cases with an interface dermatitis pattern. Arch Dermatol. 2002, 138:1258-9.","journal-title":"Arch Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5070\/D335c1029x","article-title":"Lichenoid drug eruption","volume":"15","author":"Brauer J","year":"2009","unstructured":"Brauer J, Votava HJ, Meehan S, Soter NA. Lichenoid drug eruption. Dermatol Online J. 2009, 15:13. 10.5070\/D335c1029x","journal-title":"Dermatol Online J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.320.7230.283","article-title":"Lichenoid drug eruption with proton pump inhibitors","volume":"320","author":"Bong JL","year":"2000","unstructured":"Bong JL, Lucke TW, Douglas WS. Lichenoid drug eruption with proton pump inhibitors. BMJ. 2000, 320:283. 10.1136\/bmj.320.7230.283","journal-title":"BMJ"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(93)70176-T","article-title":"Lichenoid drug eruptions","volume":"29","author":"Halevy S","year":"1993","unstructured":"Halevy S, Shai A. Lichenoid drug eruptions. J Am Acad Dermatol. 1993, 29:249-55. 10.1016\/0190-9622(93)70176-T","journal-title":"J Am Acad Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2011.01521.x","article-title":"Five cases of anti-tumor necrosis factor alpha-induced psoriasis presenting with severe scalp involvement in children","volume":"29","author":"Perman MJ","year":"2012","unstructured":"Perman MJ, Lovell DJ, Denson LA, Farrell MK, Lucky AW. Five cases of anti-tumor necrosis factor alpha-induced psoriasis presenting with severe scalp involvement in children. Pediatr Dermatol. 2012, 29:454-9. 10.1111\/j.1525-1470.2011.01521.x","journal-title":"Pediatr Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/262627-lichenoid-drug-eruption-secondary-to-adalimumab-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T13:27:27Z","timestamp":1720358847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/262627-lichenoid-drug-eruption-secondary-to-adalimumab-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,7]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.64013","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,7]]}}}